BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, April 24, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 27, 2014

View Archived Issues

Novel association found for intracranial aneurysm susceptibility

Read More

Cardioxyl Pharmaceuticals begins first trial of CXL-1427

Read More

Roche discloses novel protein ligase inhibitors for cancer

Read More

Daiichi Sankyo discloses new agents for bacterial infections

Read More

Novel thrombin inhibitors prepared at Merck & Co.

Read More

Emory University patents new NMDA receptor modulators

Read More

Amgen divulges novel TRPM8 antagonists for migraine

Read More

Long-term analysis of a prognostic gene signature for breast cancer

Read More

NICE publishes final guidance recommending Eylea in England

Read More

Known cognition enhancer active in models of neuropathic pain

Read More

Application for approval of an oral disintegrating tablet formulation

Read More

Critical Outcome Technologies signs letter of intent with Portage Biotech for COTI-2

Read More

Treatment under way in phase IIb study of brilacidin for ABSSSI

Read More

Orexigen Therapeutics receives European CHMP questions on NB-32 MAA

Read More

Bexsero available in Canada

Read More

NICE final guidance recommends Pixuvri for relapsed/refractory B-cell NHL

Read More

Phase I study of tuberculosis vaccine DAR-901 opens

Read More

Dosing completed in phase II trial of Zoenasa for ulcerative colitis

Read More

Multifunctional polynitroxylated albumin for the early treatment of stroke

Read More

Chinese researchers synthesize new PI3Kdelta inhibitors

Read More

CytoVac initiates phase II study of ALECSAT for glioblastoma multiforme

Read More

InDex Pharmaceuticals closes new rights issue

Read More

NeRRe Therapeutics initiates phase II study of orvepitant for EGFR inhibitor-induced pruritus

Read More

Mast Therapeutics opens international enrollment in EPIC study of MST-188

Read More

Adocia reports preliminary results from phase I/II trial of BioChaperone Combo

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 23, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 21, 2026
  • Green arrow on blue abstract background

    Psychedelic space expanding on Trump’s EO

    BioWorld
    Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
  • Illustration of metastatic cancer

    At AACR: Epigenetic fingerprints in metastases track tumor origin

    BioWorld
    When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
  • In the clinic for April 21, 2026

    BioWorld
    Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing